1 not yet recruiting, 1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Low-molecular weight heparin: new trials by email Literature Review of Low-molecular weight heparin trials Research Report on Low-molecular weight heparin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention rivaroxaban and ASA, Low-molecular weight heparin, Fondaparinux - Hip Fracture Surgery, Cardiovascular Prevention | Phase 3 | Not yet recruiting | McMaster University | 100 | 2025-12-01 | 2025-11-14 |
| Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism Tissue Plasminogen Activator, Alteplase, Low-molecular weight heparin - Pulmonary Embolism | Unknown | Ege University | 100 | 2022-06-03 | 2022-09-01 |
Pulmonary Embolism (1) · Venous Thromboembolism (1)
Ege University (1) · McMaster University (1)
Canada (1) · Italy (1) · Turkey (Türkiye) (1)
Federico Germini, Doctor of Medicine (1)